You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
華檢醫療(01931.HK)中期淨利1.03億元 同比增加26.9%
格隆匯 08-18 20:07

格隆匯8月18日丨華檢醫療(01931.HK)公吿,截至2023年6月30日止6個月中期業績,集團錄得收益人民幣13.77億元,同比增加17.1%。母公司擁有人應占溢利為人民幣1.03億元,同比增加26.9%。每股盈利7.62人民幣分。

集團實現收益增加主要是由於終端客户對體外診斷("IVD")產品的需求增加,這是由於醫院的營運在新型冠狀病毒疫情("COVID-19")過後逐步恢復正常。 

與2022年同期相比,集團於報吿期間的溢利亦增加49.2%。有關增加主要是由於(i)以上所述的收益增加;及(ii)2022年同期的物業、廠房及設備及無形資產減值為人民幣1952.4萬元,於報吿期間並無再次發生。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account